We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

SLX4 Products

Antibodies
SLX4 Antibody - Azide and BSA ...
SLX4 Antibody - Azide and BSA Free
H00084464-B01P
Species: Hu, Mu
Applications: WB, ICC/IF, Mycoplasma
Host: Mouse Polyclonal
Proteins
SLX4 Recombinant Protein Anti ...
SLX4 Recombinant Protein Antigen
NBP2-39070PEP
Species: Hu
Applications: AC
SLX4 Recombinant Protein Anti ...
SLX4 Recombinant Protein Antigen
NBP2-58436PEP
Species: Hu
Applications: AC

Description

SLX4 (also known as BTBD12 and FANCP) is a multidomain scaffold protein involved in DNA repair, where it has important roles in the final steps of homologous recombination. SLX4 hat interacts with three distinct nucleases: SLX1, ERCC4/XPF-ERCC1 and MUS81-EME1. Mutations in the gene are associated with the disease Fanconi anemia, a rare recessive disorder characterized by genome instability, congenital malformations, progressive bone marrow failure and predisposition to hematologic malignancies and solid tumors.

Bioinformatics

Product By Gene ID 84464
Alternate Names
  • BTB (POZ) domain containing 12
  • BTB/POZ domain-containing protein 12
  • BTBD12
  • BTBD12structure-specific endonuclease subunit SLX4
  • FANCP
  • KIAA1784
  • KIAA1784MUS312
  • KIAA1987
  • KIAA1987FANCP
  • SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae)
  • SLX4

Related SLX4 Blog Posts

Check out the latest blog posts on SLX4.
FANCD2 (Fanconi anemia subunit D2 protein)
Fanconi anemia (FANC) is a rare, autosomal-recessive genetic disorder that is a heterogeneous cancer susceptibility condition that manifests with a wide range of symptoms such as congenital malformations, deteriorating bone marrow failure, DNA-dama...    Read more.
FANCD2: A big component of the DNA repair crew
The genetic disorder known as Fanconi anemia (FANC) is a heterogeneous, autosomal-recessive cancer susceptibility condition characterized by a wide array of symptoms. These include congenital malformations, progressive bone marrow failure, DNA-damage ...    Read more.
Read more SLX4 related blogs.